Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.
about
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsBenefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.Genetic Polymorphism of CYP2C19 and Inhibitory Effects of Ticagrelor and Clopidogrel Towards Post-Percutaneous Coronary Intervention (PCI) Platelet Aggregation in Patients with Acute Coronary Syndromes.Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected].Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.Assessing the optimal strategy for dual antiplatelet therapy.Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy.Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study
P2860
Q33589630-BF752BF7-BEF8-4C08-8CF2-31D55CE457F8Q35783487-9067E909-8086-423D-8081-CAC1355C6E07Q36369122-DD62EA61-6174-4AAF-96BB-DBA3678EEC93Q37530040-CB1FC86D-C914-4798-A64F-3E28000F97E7Q38526074-3582397C-574F-49DB-AED6-907E802D5995Q43118597-277323FD-2ED2-4BB5-B676-8BE718684A6EQ48165705-3DF909F8-8937-48A0-9C3A-78D8DC84B114Q50950524-05FE104B-FED5-48BF-87DD-03C6C74B870CQ53286215-8D57A1DC-20DF-4254-947F-AC5D49BD7F19Q57153950-FA797FE4-CB1C-4061-875D-86FB60556997
P2860
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@ast
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@en
type
label
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@ast
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@en
prefLabel
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@ast
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@en
P2093
P2860
P1476
Balancing the risks of bleedin ...... apy after drug-eluting stents.
@en
P2093
Benjamin Z Galper
David J Cohen
Laura Mauri
Pallav Garg
Robert W Yeh
P2860
P304
222-233.e5
P356
10.1016/J.AHJ.2014.11.002
P407
P577
2014-11-10T00:00:00Z